Inovalon Investor Conference Presentation Deck
Continued
Strength in 2020
The Company is pleased with its
continued expansion in scale, reach,
and sophistication of its connectivity,
analytics, and value-impact, resulting
in what is being seen as a strong
continued market differentiation, very
positive sales growth, client retention
rates, revenue and profitability
expansion.
*All numbers refer to 2020 guidance provided by the Company on October 30, 2019, or
numbers as of September 30, 2019.
INOV Investor Presentation (1.14.20) v1.0.0
Market Leadership
as the industry's largest cloud-
based provider of data-driven
solutions to the healthcare
ecosystem with primary-source
datasets of
>287M
Patients
Significant
Profitability of
$231M to $241M
Adjusted EBITDA, or a
33%
Adjusted EBITDA Margin
for 2020
Strong Continuing
Organic Revenue
Growth
9% to 12%
for 2020
Strong Operating
Cash Flow of
$145M to $160M
Representing
21% to 22%
of Projected 2020 Revenue
31View entire presentation